Przejdź do zawartości
Merck
Wszystkie zdjęcia(1)

Kluczowe dokumenty

G0400007

Glycerol mono-oleate

European Pharmacopoeia (EP) Reference Standard

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych
Wszystkie zdjęcia(1)

About This Item

Wzór empiryczny (zapis Hilla):
C21H40O4
Numer CAS:
25496-72-4
Masa cząsteczkowa:
356.54
Numer MDL:
MFCD00042735
Kod UNSPSC:
41116107
NACRES:
NA.24

klasa czystości

pharmaceutical primary standard

rodzina API

glyceryl monooleate

producent / nazwa handlowa

EDQM

Zastosowanie

pharmaceutical (small molecule)

Format

neat

ciąg SMILES

O(CC(O)CO)C(=O)CCCCCCC\C=C/CCCCCCCC

InChI

1S/C21H40O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h9-10,20,22-23H,2-8,11-19H2,1H3/b10-9-

Klucz InChI

RZRNAYUHWVFMIP-KTKRTIGZSA-N

Szukasz podobnych produktów? Odwiedź Przewodnik dotyczący porównywania produktów

Opis ogólny

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Zastosowanie

Glycerol mono-oleate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Opakowanie

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Inne uwagi

Sales restrictions may apply.
Ta strona może zawierać tekst przetłumaczony maszynowo.

Kod klasy składowania

11 - Combustible Solids

Klasa zagrożenia wodnego (WGK)

WGK 1

Temperatura zapłonu (°F)

Not applicable

Temperatura zapłonu (°C)

Not applicable

Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumenty section.

Proszę o kontakt, jeśli potrzebna jest pomoc Obsługa Klienta

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Klienci oglądali również te produkty

Slide 1 of 6

1 of 6

1-Stearoyl-rac-glycerol ≥99%

Sigma-Aldrich

M2015

1-Stearoyl-rac-glycerol

1-Linoleoyl-rac-glycerol ≥97%, liquid

Sigma-Aldrich

M7640

1-Linoleoyl-rac-glycerol

1,3-Diolein ≥99% (GC)

Sigma-Aldrich

D3627

1,3-Diolein

2-Stearoylglycerol analytical standard

Supelco

36484

2-Stearoylglycerol

1,2-Dioleoyl-rac-glycerol ≥97%

Sigma-Aldrich

D8394

1,2-Dioleoyl-rac-glycerol

2-Palmitoylglycerol analytical standard

Supelco

75614

2-Palmitoylglycerol

Josephine Y T Chong et al.
Langmuir : the ACS journal of surfaces and colloids, 28(25), 9223-9232 (2012-05-29)
High-throughput methodologies have been employed to establish structure-property relationships and assess the effectiveness of nonionic steric stabilizers for inverse bicontinuous cubic lyotropic liquid crystalline nanoparticulate dispersions of monoolein and phytantriol. The ability of the stabilizers to disperse the lipids was
Chandrashekhar V Kulkarni
Nanoscale, 4(19), 5779-5791 (2012-08-18)
Lipid crystallization is ubiquitous in nature, observed in biological structures as well as in commercial products and applications. In a dehydrated state most of the lipids form well ordered crystals, whereas in an aqueous environment they self-assemble into various crystalline
Adam M Squires et al.
Langmuir : the ACS journal of surfaces and colloids, 29(6), 1726-1731 (2013-01-26)
We demonstrate a method by which we can produce an oriented film of an inverse bicontinuous cubic phase (Q(II)(D)) formed by the lipid monoolein (MO). By starting with the lipid as a disordered precursor (the L(3) phase) in the presence
Victoria M Steffes et al.
Biomaterials, 145, 242-255 (2017-09-11)
Lipid-based particles are used worldwide in clinical trials as carriers of hydrophobic paclitaxel (PTXL) for cancer chemotherapy, albeit with little improvement over the standard-of-care. Improving efficacy requires an understanding of intramembrane interactions between PTXL and lipids to enhance PTXL solubilization
Jaclyn M Hosmer et al.
Pharmaceutical research, 30(3), 694-706 (2012-11-09)
To develop liquid crystalline phases with monoglycerides, and assess whether the monoglyceride type favors cutaneous over transdermal paclitaxel delivery. BRIJ-based lamellar phases were prepared with 0.5% paclitaxel and 20% of either monocaprylin (LP-MC), monomyristolein (LP-MM) or monoolein (LP-MO). Skin electrical
Wyświetl wszystkie powiązane dokumenty

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej